CSA-D44

N/A

Report date: 2022/11/20 20:50:23

NME

Base Information

Drug NameCSA-D44

Drug Alias NameCSA-D44

ClassificationSmall molecules > Synthetic peptide

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsDiabetic FootImpetigo

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesCsa Biotech

China Registration ClassN/A

Develop Information

Active CompaniesCsa Biotech

Inactive CompaniesN/A

Active IndicationsDiabetic FootImpetigo

Inactive IndicationsN/A

Other Information

ATC CodeN/A

Related LinksN/A